2020
Gawade PL, Li S, Henry D, Smith N, Belani R, Kelsh MA , et al. Patterns of granulocyte colony-stimulating factor prophylaxis in patients with cancer receiving myelosuppressive chemotherapy. 2020. Support Care Cancer 28(9):4413–4424.
View Abstract
Topics: Cancer
Hawkins A, Murphy A, McNamara M, Gawade PL, Belani R, Kelsh MA . A survey of oncologists’ perceptions and opinions regarding the use of granulocyte colony-stimulating factors. 2020. J Cancer Edu 35(1):178–186.
View Abstract
Topics: Cancer
Hawkins A, Murphy A, McNamara M, Gawade PL, Belani R, Kelsh MA . 2020. A survey of oncologists’ perceptions and opinions regarding the use of granulocyte colony-stimulating factors. J Cancer Edu 35(1):178–186.
View Abstract
Topics: Cancer
Locatelli F, Whitlock JA, Peters C, Chen-Santel C, Chia V, Dennis RM, … Kelsh MA , et al. 2020. Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia. Leukemia 34(9):2473–2478; doi: 10.1038/s41375-020-0770-8 . PMID: 32094465.
View Abstract
Topics: Cancer , Epidemiology
Ravandi F, Pierce S, Garcia-Manero G, Kadia T, Jabbour E, Borthakur G, … Kelsh M , et al. 2020. Salvage therapy outcomes in a historical cohort of patients with relapsed or refractory acute myeloid leukemia. Clin Lymphoma Myeloma Leuk 20(11):e871–e882.
View Abstract
Topics: Cancer , Epidemiology
Gage SM, Reichert H . 2020. Determining the incidence of needle-related complications in hemodialysis access: We need a better system. J Vascular Access 22(4)521-532; doi: 10.1177/1129729820946917 .
View Abstract
Topics: Epidemiology
Thompson CM, Donahue DA, Hobbs C, Costecalde Y, Franzen A, Suh M , Proctor DM, Harris MA. 2020. Exposure to environmentally-relevant concentrations of hexavalent chromium does not induce ovarian toxicity in mice. Regul Toxicol Pharmacol 116:104729; doi: 10.1016/j.yrtph.2020.104729 .
View Abstract